Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bonomi

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|April 1, 1988
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifenP Bonomi, M Gale, J Von Roenn, et al.
Cancer Investigation|January 1, 1997
Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseasesH D Preisler, A Raza, P Bonomi, et al.
Seminars in Oncology|August 1, 1997
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiationP Bonomi, L P Faber, W Warren, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trialsM Extermann, M Bonetti, G W Sledge, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinomaK M Rowland, P Bonomi, S G Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trialP Bonomi, K Kim, D Fairclough, et al.
Anticancer Research|January 1, 1981
Neuroendocrine small cell carcinomas in miscellaneous primary sites: implications for staging and therapyR Pazdur, P Bonomi, V E Gould, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1995
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrumentD F Cella, A E Bonomi, S R Lloyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group studyP Bonomi, J A Blessing, F B Stehman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology GroupD H Johnson, A T Turrisi, A Y Chang, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|April 1, 1988
Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifenP Bonomi, M Gale, J Von Roenn, et al.
Cancer Investigation|January 1, 1997
Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseasesH D Preisler, A Raza, P Bonomi, et al.
Seminars in Oncology|August 1, 1997
Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiationP Bonomi, L P Faber, W Warren, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trialsM Extermann, M Bonetti, G W Sledge, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinomaK M Rowland, P Bonomi, S G Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trialP Bonomi, K Kim, D Fairclough, et al.
Anticancer Research|January 1, 1981
Neuroendocrine small cell carcinomas in miscellaneous primary sites: implications for staging and therapyR Pazdur, P Bonomi, V E Gould, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1995
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrumentD F Cella, A E Bonomi, S R Lloyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group studyP Bonomi, J A Blessing, F B Stehman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology GroupD H Johnson, A T Turrisi, A Y Chang, et al.
Pageof 10